RHYTHM PHARMACEUTICALS, INC. (RYTM) Net income 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$196.5MFY2025 · since FY2016: -$25.9M → -$196.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$196.5M | +24.6% |
| FY2024 | -$260.6M | -41.1% |
| FY2023 | -$184.7M | -2.0% |
| FY2022 | -$181.1M | -160.2% |
| FY2021 | -$69.6M | +48.0% |
| FY2020 | -$134.0M | +4.8% |
| FY2019 | -$140.7M | -90.0% |
| FY2018 | -$74.1M | -119.7% |
| FY2017 | -$33.7M | -30.3% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net marginRYTM Gross profitRYTM Gross marginRYTM Operating incomeRYTM Operating marginRYTM Operating cash flowRYTM Free cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Total liabilitiesRYTM Shareholders’ equityRYTM overview →